Drug Profile
Ertapenem controlled release - scPharmaceuticals
Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator scPharmaceuticals
- Class Amides; Anti-infectives; Antibacterials; Benzoic acids; Carbapenems; Pyrrolidines; Small molecules; Sulfides
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bacterial infections; Community-acquired pneumonia; Diabetic foot ulcer; Intra-abdominal infections; Skin and soft tissue infections; Urinary tract infections
Most Recent Events
- 07 Mar 2017 Chemical structure information added
- 01 Feb 2017 Clinical trials in Bacterial infections (SC)
- 01 Feb 2017 Clinical trials in Community-acquired pneumonia (SC)